D-0072-2024 Class III Terminated
FDA drug recall D-0072-2024 was initiated by Denver Solutions, LLC DBA Leiters Health on Oct 4, 2023 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified The recall status is terminated (terminated Aug 15, 2024). Affected quantity: 25,908 IV bags.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 1, 2023
- Initiation Date
- Oct 4, 2023
- Termination Date
- Aug 15, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 25,908 IV bags
Product description
VANCOmycin HCI PF, 1.5 g added to 0.9% Sodium Chloride 250 mL IV Bag, Rx only, Leiters Compounding Health, 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-029-68.
Reason for recall
Labeling: Not Elsewhere Classified
Distribution pattern
USA Nationwide
Code information
Lot#: 2330792, Exp. 12/17/23; 2330801, Exp. 12/26/23; 2330821, 10/15/23; 2330823, Exp. 10/21/23; 2330825, Exp. 10/27/23; 2330846, Exp. 10/28/23; 2330847, Exp. 11/03/23; 2330856, 11/17/23; 2330858, Exp. 12/03/23; 2330860, 12/15/23; 2330866, Exp. 12/29/23; 2331053, Exp. 01/13/24.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0072-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026